.svg){kind=small}
Nov-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
In California, Kind Medicine has shown a varied performance across different product categories. In the Capsules category, the brand maintained a consistent presence, ranking 15th in both August and November 2024, although it dropped out of the top 30 in September and October. This indicates some volatility, but the ability to regain its position by November suggests resilience. The sales figures for Capsules show a slight decline from August to November, which could point to a need for strategic adjustments. On the other hand, in the Tincture & Sublingual category, Kind Medicine ranked 22nd in August, dropped out of the top 30 in September, but impressively climbed to 21st in October. This upward movement in October, accompanied by an increase in sales, showcases potential growth in this segment.
While Kind Medicine's performance in California is noteworthy, the absence of rankings in several months across both categories highlights areas for improvement. Not being in the top 30 for the Capsules category in September and October, as well as missing September and November rankings for Tinctures & Sublinguals, suggests that while there are strengths, there are also significant opportunities for Kind Medicine to enhance its market presence. The fluctuating rankings and sales figures underscore the competitive nature of the cannabis market in California, urging the brand to potentially diversify its strategies to gain a steadier foothold. This analysis provides a glimpse into the brand's current standing and the dynamic nature of its market engagement.
Competitive Landscape
In the competitive landscape of cannabis capsules in California, Kind Medicine has experienced fluctuating rankings, indicating a dynamic market presence. Notably, Kind Medicine was ranked 15th in August 2024, dropped out of the top 20 in September and October, and then re-entered at 15th in November. This suggests a volatile market position compared to competitors like Press, which maintained a steady climb from 14th to 13th place over the same period, reflecting a consistent increase in sales. Meanwhile, Lights Out experienced a slight decline from 13th to 14th place, indicating potential market challenges. Heavy Hitters consistently held the 8th position in August and September before dropping out of the top 20, suggesting a significant shift in market dynamics. These insights highlight the competitive pressures Kind Medicine faces, emphasizing the need for strategic adjustments to improve its market standing and sales trajectory.
Notable Products
In November 2024, the top-performing product for Kind Medicine was Indica Capsules 2-Pack (60mg) in the Capsules category, which climbed to the number one position from being unranked in previous months, achieving sales of 90 units. Sativa Capsules 10-Pack (300mg) secured the second spot, a notable rise from being unranked in October. Following closely, Sativa Capsules 2-Pack (60mg) ranked third, showing a consistent presence in the top five from September. Indica Capsules 10-Pack (300mg) dropped to the fourth rank, indicating a slight decrease in its sales momentum compared to earlier months. The CBD/THC 25:1 Pet Tincture (500mg CBD, 20mg THC, 30ml) maintained its position at fifth place, showing stability in its sales performance.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
